Management of Persistent Symptoms After Left SSV Radiofrequency Ablation

Patient Assessment and Symptoms

A 59-year-old male patient reports only 70% improvement in symptoms after left SSV radiofrequency ablation, with persistent symptoms including achy, tired legs, and sensation of heaviness despite conservative management with physical therapy, walking, and compression stockings for 7 months, according to the American Family Physician 1
The patient's activities of daily living continue to be affected, particularly walking and standing for long periods, as reported in the American Family Physician 1
Pain is rated at 4-5/10 despite conservative measures, as noted in the American Family Physician 1

Recent duplex ultrasound confirms that the left SSV remains properly closed above the distal calf following RFA, as reported in Praxis Medical Insights 2
The ultrasound notes "remaining SSV reflux branches LEFT," but there is no specific documentation of reflux duration ≥500 milliseconds in these tributary branches, according to Praxis Medical Insights 3

For foam sclerotherapy to be considered medically necessary, vein size must be ≥2.5mm in diameter, measured by recent ultrasound, and documented reflux duration ≥500 milliseconds in the veins to be treated, as stated in Praxis Medical Insights 3, 4
Symptoms must be persisting despite a 3-month trial of conservative management, according to Praxis Medical Insights 3

Sclerotherapy is generally indicated for small to medium-sized varicose veins with documented reflux and diameter ≥2.5mm, as reported in Praxis Medical Insights 2, 3
Foam sclerotherapy has occlusion rates varying from 72-89% at 1 year when used appropriately, according to Praxis Medical Insights 3

Continued conservative management with compression therapy is recommended for persistent symptoms despite successful closure of the main saphenous trunk, as suggested by the American Family Physician and Praxis Medical Insights 1, 4
Consideration of microphlebectomy for symptomatic small varicose veins that don't meet size criteria for sclerotherapy, as reported in Praxis Medical Insights 4